Pharmafile - Business Services News

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn's Disease

Phlo raises £10m to spearhead digital transformation in pharmacy sector

Novartis announces cut to multiple drug research programmes in 2022 full-year report

Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, including their...

Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics

US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.

PureTech to Present at the SVB Securities Global Biopharma Conference

Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia

ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization

Sequana Medical announces grant of additional DSR® patent in United States

Neuraxpharm announces closing of acquisition of established products from Sanofi

Mission Statement

Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,

Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches